Roche Holdings AG Basel/ US7711951043 /
| 2024-04-25 9:59:59 PM | Chg. -0.5200 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 30.0200USD | -1.70% | 3.93 mill. Turnover: 79.61 mill. |
-Bid Size: - | -Ask Size: - | 30.1600 | 29.8000 |
GlobeNewswire
2019-05-16
Roche announces FDA approval for Venclexta plus Gazyva for people with previously untreated chronic ...
GlobeNewswire
2019-05-16
Roche's personalised medicine entrectinib shrank tumours harbouring NTRK, ROS1 or ALK gene fusions i...
GlobeNewswire
2019-05-14
New Roche test aids clinicians in accelerating tuberculosis diagnosis and treatment by detecting ant...
GlobeNewswire
2019-05-14
Roche and Spark Therapeutics, Inc. announce expected refiling date of Premerger Notification and Rep...
GlobeNewswire
2019-05-10
Roche to present new data highlighting comprehensive approach to cancer care at 2019 American Societ...
GlobeNewswire
2019-05-08
Roche to present new OCREVUS (ocrelizumab) data analyses showing significant reduction of disability...
GlobeNewswire
2019-05-07
Roche presents data from the risdiplam pivotal FIREFISH and SUNFISH studies in spinal muscular atrop...
GlobeNewswire
2019-05-06
FDA approves Roche's Kadcyla for adjuvant treatment of people with HER2-positive early breast cancer...
GlobeNewswire
2019-04-29
New Roche data at the 2019 AAN Annual Meeting showcase breadth and promise of neuroscience portfolio
GlobeNewswire
2019-04-26
Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Re...
GlobeNewswire
2019-04-23
Roche launches new VENTANA HER2 Dual ISH companion diagnostic test for breast and gastric cancer pat...
GlobeNewswire
2019-04-17
Roche reports a strong start in 2019 and raises the outlook for the full-year
GlobeNewswire
2019-04-03
Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Re...
GlobeNewswire
2019-04-01
Roche's ipatasertib in combination with Tecentriq and chemotherapy shows promising anti-tumour activ...
GlobeNewswire
2019-03-19
FDA approves Roche's Tecentriq in combination with chemotherapy for the initial treatment of adults ...
GlobeNewswire
2019-03-15
European Commission approves Roche's MabThera (rituximab) for a rare autoimmune disease
GlobeNewswire
2019-03-14
European Commission approves Roche's Hemlibra for people with severe haemophilia A without factor VI...
GlobeNewswire
2019-03-11
Roche's VENTANA PD-L1 (SP142) Assay approved as first companion diagnostic to identify triple-negati...
GlobeNewswire
2019-03-11
FDA grants Roche's Tecentriq in combination with Abraxane accelerated approval for people with PD-L1...
GlobeNewswire
2019-03-08
European Commission approves Roche's Tecentriq in combination with Avastin and chemotherapy for the ...
GlobeNewswire
2019-03-07
Roche commences tender offer for all shares of Spark Therapeutics, Inc. for US$ 114.50 per share in ...
